Results 171 to 180 of about 768,287 (304)
ABSTRACT Background Hereditary factor X (FX) deficiency is a rare autosomal recessive bleeding disorder for which individualized pharmacokinetic (PK) assessment can support optimized prophylactic management. The WAPPS‐Hemo platform enables population pharmacokinetic (PopPK) individualized PK predictions based on sparse sampling.
Dagmar M. Hajducek +4 more
wiley +1 more source
Perioperative Management in Persons With Haemophilia on Rebalancing Therapies: A Narrative Review
ABSTRACT Introduction Perioperative management in haemophilia often requires on‐demand use of clotting factor concentrates (CFC) and/or bypassing agents. Rebalancing agents (fitusiran, concizumab, marstacimab) offer a novel approach to prophylaxis by modulating endogenous anticoagulant pathways to restore haemostatic balance.
Amanda M. Henderson +2 more
wiley +1 more source
Surface cues shape procoagulant properties of amyloidogenic microclots. [PDF]
Pretorius E +4 more
europepmc +1 more source
Shared Decision‐Making in Haemophilia Involves More Treatment Differentiators in 2026
ABSTRACT Introduction Shared decision‐making regarding treatment choice in haemophilia care has become increasingly more complex and essential due to the availability of several innovative therapeutics that are characterized by their own advantages and limitations, which need to be tailored to individual patient needs.
Quentin Van Thillo +2 more
wiley +1 more source
Key Players and Pathways of Mast Cell Activation in Urticaria. [PDF]
Jahn C +4 more
europepmc +1 more source
Abstract Background Coagulation testing in persons with hemophilia A (PwHA) is required for diagnosis, monitoring replacement therapy, assessment of adherence, and detection of inhibitors. However, data on testing practices are limited, and alignment with guideline recommendations is unclear.
A. P. Bavinck +4 more
wiley +1 more source
Trafficking thrombin receptors
Lawrence F. Brass +2 more
openaire +1 more source
Protease-activated receptor 1 as an endogenous model of peptidergic Gαq-Gα12-biased G protein signaling. [PDF]
Fallon BS, Campbell RA, English JG.
europepmc +1 more source
Merlin CP‐GEP integrates mechanistic insights into a clinically actionable assay to predict SLN metastasis risk and inform personalized management of cutaneous melanoma. ABSTRACT The recent inclusion of the Merlin clinicopathologic–gene expression profile (CP‐GEP) assay in the National Comprehensive Cancer Network (NCCN) Melanoma Guidelines represents ...
Frank Z. Jing, Alexander Meves
wiley +1 more source
Antiplatelet effect of spironolactone via modulation of cPLA₂-mediated thromboxane A₂ generation in murine platelets. [PDF]
Kim S, Chaudhary PK, Yang S, Kim S.
europepmc +1 more source

